dobutamine has been researched along with Tachycardia, Supraventricular in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (50.00) | 18.2507 |
| 2000's | 1 (16.67) | 29.6817 |
| 2010's | 1 (16.67) | 24.3611 |
| 2020's | 1 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Araújo, I; Campos, L; Cunha, GJL; Fernandes, L; Ferraz, M; Fonseca, C; Gomes, RV; Morais, R; Rocha, BML | 1 |
| Mularski, S; Němec, J; Saba, S; Seethala, S; Shusterman, V | 1 |
| Hall, CM; Ward Platt, MP | 1 |
| Bigi, R; Mathias, W; Picano, E; Pingitore, A; Previtali, M | 1 |
| Kapoor, C; Mehra, MR; Smart, FW; Stapleton, DD; Ventura, HO; Zimmerman, D | 1 |
| Blissitt, KJ; Clutton, RE; Molony, V; Young, LE | 1 |
2 trial(s) available for dobutamine and Tachycardia, Supraventricular
| Article | Year |
|---|---|
Safety and tolerability of dobutamine-atropine stress echocardiography: a prospective, multicentre study. Echo Dobutamine International Cooperative Study Group.
Topics: Atropine; Coronary Disease; Dobutamine; Echocardiography; Female; Hallucinations; Humans; Male; Middle Aged; Myocardial Infarction; Prospective Studies; Safety; Tachycardia, Supraventricular; Ventricular Fibrillation | 1994 |
Safety and clinical utility of long-term intravenous milrinone in advanced heart failure.
Topics: Adult; Aged; Cardiotonic Agents; Cohort Studies; Dobutamine; Drug Administration Schedule; Drug Therapy, Combination; Female; Heart Failure; Hemodynamics; Humans; Hypotension; Injections, Intravenous; Male; Middle Aged; Milrinone; Phosphodiesterase Inhibitors; Prospective Studies; Pyridones; Survival Rate; Tachycardia, Supraventricular; Tachycardia, Ventricular; Thrombocytopenia; Treatment Outcome | 1997 |
4 other study(ies) available for dobutamine and Tachycardia, Supraventricular
| Article | Year |
|---|---|
Levosimendan with other inotropes or vasopressors: Should you combine them?
Topics: Acute Disease; Aged; Aged, 80 and over; Arterial Pressure; Cardiotonic Agents; Dobutamine; Dopamine; Drug Therapy, Combination; Female; Heart Failure; Heart Rate; Hospital Mortality; Humans; Hypotension; Length of Stay; Male; Middle Aged; Norepinephrine; Simendan; Tachycardia, Supraventricular; Treatment Outcome; Vasoconstrictor Agents | 2020 |
Effect of β-adrenergic stimulation on QT interval accommodation.
Topics: Adaptation, Physiological; Adrenergic beta-1 Receptor Antagonists; Adult; Cardiac Pacing, Artificial; Catheter Ablation; Dobutamine; Drug Administration Schedule; Electrocardiography; Female; Follow-Up Studies; Heart Rate; Humans; Infusions, Intravenous; Linear Models; Long QT Syndrome; Male; Middle Aged; Sampling Studies; Severity of Illness Index; Tachycardia, Supraventricular; Treatment Outcome | 2011 |
Neonatal flecainide toxicity following supraventricular tachycardia treatment.
Topics: Anti-Arrhythmia Agents; Dobutamine; Enoximone; Female; Fetal Diseases; Flecainide; Humans; Infant, Newborn; Maternal-Fetal Exchange; Pregnancy; Tachycardia, Supraventricular | 2003 |
Temporal effects of an infusion of dobutamine hydrochloride in horses anesthetized with halothane.
Topics: Anesthesia, Inhalation; Anesthetics, Inhalation; Animals; Blood Pressure; Cardiac Catheterization; Cardiac Output; Diastole; Dobutamine; Echocardiography, Transesophageal; Halothane; Heart Rate; Hemodynamics; Horses; Infusions, Intravenous; Tachycardia, Supraventricular; Time Factors; Ventricular Function, Left | 1998 |